{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:33:06Z","timestamp":1770741186561,"version":"3.49.0"},"reference-count":0,"publisher":"Oceanside Publications Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.2500\/aap.2019.40.4236","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T21:05:34Z","timestamp":1564088734000},"page":"321-328","source":"Crossref","is-referenced-by-count":13,"title":["Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study"],"prefix":"10.2500","volume":"40","author":[{"given":"Abhishek","family":"Kavati","sequence":"first","affiliation":[{"name":"From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryia","family":"Zhdanava","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ortiz","sequence":"additional","affiliation":[{"name":"From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"LeCocq","sequence":"additional","affiliation":[{"name":"From the Novartis Pharmaceutical Corporation, East Hanover, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradd","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Allergy Partners P.A., Asheville, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Pilon","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoi","family":"Ching Cheung","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Stone","sequence":"additional","affiliation":[{"name":"Allergy Partners of San Diego, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2019\/00000040\/00000005\/art00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:40:13Z","timestamp":1568335213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2019.40.4236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["1088-5412(20190901)40:5L.321;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2019.40.4236","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}